Insight on Pharmaceuticals and Healthcare in Europe

Published within

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

Type Product title / description Pub Price
Report
Report

Russia Pricing and Reimbursement

Overview of pricing and reimbursement trends in the Russian pharmaceutical market.

Published By Datamonitor
15 Jan 2013 $1520
Buy
Report
Report

Russia Pharmaceutical Market Overview - Pharma companies target Russia despite the challenges it presents

Overview of the Russian pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.

Published By Datamonitor
23 Nov 2010 $7600
Buy
Report
Report

Russia Generics and Biosimilars

Branded generics produced by foreign companies continue to dominate the market.

Published By Datamonitor
01 Mar 2013 $1520
Buy
Report
Report

Rheumatoid Arthritis - Pipeline

Review of candidates in development for rheumatoid arthritis across the US, Japan, and five major EU markets.

Published By Datamonitor
03 Dec 2013 $2000
Buy
Report
Report

Rheumatoid Arthritis - Marketed Drugs

In-depth analysis of marketed drugs for rheumatoid arthritis, including lifecycle management strategies, new clinical data and an evaluation of clinical and commercial drug attributes to understand competitiveness in the marketplace.

Published By Datamonitor
03 Dec 2013 $2000
Buy
Report
Report

Rheumatoid Arthritis - Forecast

Becoming increasingly difficult for developers of novel products to penetrate the rheumatoid arthritis market

Published By Datamonitor
03 Dec 2013 $2000
Buy
Report
Report

R&D Trends: Women's Health - Investment needed to address lack of innovation

Review of key trends in the development of new women’s health drugs across the seven major markets with particular emphasis on contraception, menopausal symptoms, endometriosis, uterine fibroids, infertility, and female sexual dysfunction.

Published By Datamonitor
05 Dec 2011 $2800
Buy
Report
Report

R&D Trends: Systemic Lupus Erythematosus - Benlysta’s FDA approval provides hope for disease treatment, future trial design, and other pipeline candidates

Review of candidates in development for systemic lupus erythematosus (SLE) across the seven major markets, highlighting key trends, as well as detailed analyses of clinical trial design, innovative early-stage projects and future treatment.

Published By Datamonitor
26 May 2011 $2800
Buy
Report
Report

R&D Trends: Skin and soft tissue infections - MRSA threat drives R&D interest in an increasingly fragmented market

The emergence of methicillin-resistant Staphylococcus aureus (MRSA) has driven R&D interest in skin and soft tissue infections (SSTIs). This module reviews pipeline trends, clinical trial design, and future treatment paradigms for SSTIs.

Published By Datamonitor
05 Jul 2011 $2800
Buy
Report
Report

R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapy

Progress in sepsis drug development has been severely hindered by the complex disease pathogenesis and patient heterogeneity. This module reviews pipeline trends, clinical trial design, and future treatment paradigms for sepsis.

Published By Datamonitor
06 Apr 2011 $2800
Buy

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

No help is available.